Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

982 recalls · Class II, newest first

Class II · Moderate risk

Diarrhea Response Homeopathic Formula

CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.

Terminated Microbial contamination Beaumont Bio-med, Inc. NDC 58066-7022-7 D-1195-2018
Class II · Moderate risk

Sinus Response Homeopathic Formula

CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.

Terminated Microbial contamination Beaumont Bio-med, Inc. NDC 58066-7013-7 D-1193-2018
Class II · Moderate risk

Thyroid powder

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Alkano Chemicals, Inc NDC 7807-0170-11 D-0008-2019
Class II · Moderate risk

Thyroid

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Humco Holding Group, Inc NDC 0395-6580-43 D-0024-2019
Class II · Moderate risk

Thyroid

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Humco Holding Group, Inc NDC 0395-8077-62 D-0023-2019
Class II · Moderate risk

Thyroid

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Humco Holding Group, Inc NDC 0395-8077-43 D-0022-2019
Class II · Moderate risk

Ethosuximide Capsules

Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.

Terminated Impurity / degradation Akorn, Inc. D-1183-2018
Class II · Moderate risk

Thyroid Powder

CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation LGM Pharma LLC D-0296-2019
Class II · Moderate risk

Cortaid 12-Hour Advanced Anti-itch Cream

CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.

Terminated Microbial contamination Valeant Pharmaceuticals North America LLC D-0086-2019
Class II · Moderate risk

Cortaid Maximum Strength Cream

CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.

Terminated Microbial contamination Valeant Pharmaceuticals North America LLC D-0085-2019
Class II · Moderate risk

Cortaid Intensive Therapy Cooling Spray

CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.

Terminated Microbial contamination Valeant Pharmaceuticals North America LLC D-0084-2019
Class II · Moderate risk

Cefuroxime 10mg/mL INJ 0.5 mg

Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after use of product.. FDA analysis identified the particulate as coring of the rubber stopper

Terminated Particulate / foreign matter Pacific Compounding Pharmacy & Consultations Inc D-1076-2019
Class II · Moderate risk

Thyroid Powder USP

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Syntec Pharma Corp D-0014-2019
Class II · Moderate risk

Thyroid Powder USP

CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.

Terminated cGMP deviation Syntec Pharma Corp D-0013-2019
Class II · Moderate risk

Methyl-Cobalamin injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1167-2018
Class II · Moderate risk

Folic Acid injectable

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Terminated Sterility / contamination Auro Pharmacies, Inc. D-1166-2018

Recalls by year